The Analysis On The Patent Information Of Anti-Alzheimer’s Chemical Drugs At Home And Abroad

At present,with the increasingly serious problem of population aging,the number of Alzheimer’s disease patients is increasing Worldwide.There are only six drugs approved by the FDA for the treatment of this disease,and the market for the treatment of this disease is in great demand.The development of effective drugs for the treatment of Alzheimer’s disease has become a research hotspot in the global pharmaceutical field.Pharmaceutical patents are the most important pharmaceutical intellectual property rights,and pharmaceutical patents will be fully utilized in the entire process of drug development.The development of the pharmaceutical industry is inseparable from the innovation of drug research and development technology,and technological innovation needs the support of medical patents.Therefore,in order to make domestic drug research and development institutions grasp the development trends of drugs and the international competition situation of drugs at the first time,it is necessary to use the patent analysis method to sort out the patent information of AD chemical drugs at home and abroad.Use the comparative study method to compare domestic and foreign patents,so as to clarify the status of my country’s AD chemical drug patent technology in the world,find out the deficiencies in the development of domestic AD chemical drug patent technology,and analyze the causes,so as to propose domestic AD chemical drugs The development strategy of patented technology,so as to realize the innovation and development of drug research and development technology.This article uses the patent analysis method and combines the professional knowledge of pharmacy to mine and interpret the patents of chemical drugs for Alzheimer’s disease at home and abroad.It mainly includes the following three aspects:First,a total of 137,538 global patent data are collected and analyzed in detail from five perspectives: patent application trend,technology life cycle,regional competition situation,major patent holders,and core patents.Second,a total of 6,857 domestic patent data were collected,and these patents were analyzed in detail from the above five perspectives.Third,compare and analyze domestic and foreign patents.Through the comparative analysis of the status and trends of domestic and foreign patents,it is concluded that the overall quality of patents in the field of AD chemical drugs in China is low,the awareness of intellectual property rights is weak,the distribution of applicants is unreasonable,and the core patents are few.the reasons behind.On the basis of analyzing the shortage of domestic AD chemical drug patent technology and its causes,corresponding policies and suggestions are put forward from the three levels of the country,industry and enterprise.At the national level: formulate strong innovation incentive policies according to the actual situation of my country’s pharmaceutical industry;encourage the coordinated development of eastern and western regions,and improve the overall quality of domestic patents.At the industry level: optimize resource allocation and accelerate industrial restructuring;encourage the pharmaceutical industry to cultivate high-value patents.Enterprise level:Enterprises should improve their independent research and development capabilities,pay attention to internal intellectual property management,learn foreign patent distribution strategies,and improve their own patent distribution capabilities.Innovative development countermeasures are proposed from the perspectives of multiple subjects,so as to promote the innovative development of the domestic AD chemical drug field.